Personal profile
Headline
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A systematic review of gene-mediated therapy in BCG-unresponsive NMIBC: emerging evidence and future perspectives
Bertrand, C., Ouzaid, I., Guerrero-Ramos, F., Marcq, G., Sfakianos, J. P., Xylinas, E. & Gabriel, P. E., Dec 2026, In: World Journal of Urology. 44, 1, 44.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Circulating Plasma and Urine Tumor DNA in Non–muscle-invasive Bladder Cancer: A Promising Biomarker to Guide Therapeutic Intensification
Gabriel, P. E., Marcq, G., Zhu, A., Sfakianos, J. P. & Xylinas, E., 2026, (Accepted/In press) In: European Urology Open Science.Research output: Contribution to journal › Letter › peer-review
Open Access -
Circulating Tumor DNA in Bladder Cancer: A New Treatment Paradigm?
Anderson, C. B. & Sfakianos, J. P., Mar 2026, In: Journal of Urology. 215, 3, p. 256-257 2 p.Research output: Contribution to journal › Editorial
-
Erratum: Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors
Hassoun, R., Ben-David, R., Sfakianos, J. P., Laliotis, G., Au, C., Cary, C., Masterson, T. A., Manage, K., Dutta, P., Tillu, N., Cumarasamy, S., King, J., Rich, J., Rock, A., Dorff, T., Patel, M., Sharma, S., ElNaggar, A. C., Liu, M. C. & Tan, A. & 3 others, , Mar 2026, In: JCO Precision Oncology. 10, e2600181.Research output: Contribution to journal › Comment/debate
-
Long-term oncological outcomes of bladder cancer: a population-based study with a 25-year follow-up
Dey, L., Rautiola, J., Akre, O., Egevad, L., Hosseini, A., Mehrazin, R., Patrakka, J., Ranti, D., Renström-Koskela, L., Sfakianos, J., Thiel, T., Vincent, P. H., Yan, J., Steineck, G. & Wiklund, P., Jan 2026, In: BJU International. 137, 1, p. 95-102 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
Press/Media
-
Investigators at Icahn School of Medicine at Mount Sinai Zero in on Bladder Cancer (Therapeutic efficacy of Gemcitabine/Docetaxel maintenance in patients with non-muscle-invasive bladder cancer receiving initial Bacillus Calmette-Guerin ...)
Mehrazin,, R., Sfakianos, J. & Wiklund, P.
2/04/26
1 item of Media coverage
Press/Media
-
New Findings from Icahn School of Medicine at Mount Sinai in the Area of Bladder Cancer Described (Comparative Effectiveness of Bacillus Calmette-guerin and Sequential Intravesical Gemcitabine and Docetaxel for Treatment-naive Intermediate-risk ...)
Mehrazin,, R., Sfakianos, J., Wiklund, P. & Attalla, K.
26/02/26
1 item of Media coverage
Press/Media
-
Panel Expresses Support for Urine-Based Biomarkers
22/02/26 → 25/02/26
24 items of Media coverage
Press/Media
-
Mount Sinai Study May Help Cancer Patients Keep Their Bladder
Izadmehr, S., Mehrazin,, R., Sfakianos, J., Galsky, M., Chowell, D. & Brody, R.
19/02/26 → 20/02/26
4 items of Media coverage
Press/Media
-
Findings from Icahn School of Medicine at Mount Sinai Broaden Understanding of Bladder Cancer (Bladder Cancer with Undetectable Circulating Tumor DNA After Radical Cystectomy May Be Amenable to a Less Intense Imaging Surveillance Protocol: A ...)
Mehrazin,, R., Sfakianos, J., Wiklund, P., Attalla, K. & Waingankar, N.
19/12/25
1 item of Media coverage
Press/Media